Mozart Therapeutics Funding: $80M Raised, Series A (2023)
Mozart Therapeutics is based in Seattle, WA. It has raised $80M in total funding. Latest round: Series A.
Mozart Therapeutics funding overview
Mozart Therapeutics is based in Seattle, WA. Mozart Therapeutics has raised $80M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in January 2023. The round record for Mozart Therapeutics runs through 2023; nothing later has been disclosed. Investors on record include ARCH Venture Partners, Sofinnova Partners, Eli Lilly & Company, MRL Ventures Fund, Leaps by Bayer, Altitude Life Science Ventures and 5 others. 11 distinct backers are named across the disclosed rounds.
Mozart Therapeutics at a glance
Total raised
$80M
Latest round
Series A
Latest round date
January 2023
Headquarters
Seattle, WA
Notable investors
ARCH Venture Partners, Sofinnova Partners, Eli Lilly & Company, MRL Ventures Fund, Leaps by Bayer, Altitude Life Science Ventures, Alexandria Venture Investments, Pfizer Ventures
Frequently asked about Mozart Therapeutics funding
How much has Mozart Therapeutics raised?
Mozart Therapeutics has raised $80M in total disclosed funding across the rounds on record.
Who has invested in Mozart Therapeutics?
ARCH Venture Partners, Sofinnova Partners, Eli Lilly & Company, MRL Ventures Fund, Leaps by Bayer, Altitude Life Science Ventures are named among the investors backing Mozart Therapeutics.
What was the latest Mozart Therapeutics funding round?
The most recent disclosed round is a Series A, announced in January 2023.
Where is Mozart Therapeutics based?
Mozart Therapeutics is based in Seattle, WA.
When did Mozart Therapeutics last raise?
The last disclosed Mozart Therapeutics round closed in January 2023 at Series A.
Totals shown for Mozart Therapeutics aggregate every disclosed round on file. To see how that compares, browse the companies in Seattle and the investors behind them below.
